Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

A mutation in Hnrnph1 that decreases methamphetamine-induced reinforcement, reward, and dopamine release and increases synaptosomal hnRNP H and mitochondrial proteins.

Ruan QT, Yazdani N, Blum BC, Beierle JA, Lin W, Coelho MA, Fultz EK, Healy AF, Shahin JR, Kandola AK, Luttik KP, Zheng K, Smith NJ, Cheung J, Mortazavi F, Apicco DJ, Ragu Varman D, Ramamoorthy S, Ash PEA, Rosene DL, Emili A, Wolozin B, Szumlinski KK, Bryant CD.

J Neurosci. 2019 Nov 8. pii: 1808-19. doi: 10.1523/JNEUROSCI.1808-19.2019. [Epub ahead of print]

PMID:
31704785
2.

Prior binge-drinking history promotes the positive affective valence of methamphetamine in mice.

Fultz EK, Szumlinski KK.

Drug Alcohol Depend. 2018 Feb 1;183:150-154. doi: 10.1016/j.drugalcdep.2017.10.034. Epub 2017 Dec 11.

3.

Methamphetamine-alcohol interactions in murine models of sequential and simultaneous oral drug-taking.

Fultz EK, Martin DL, Hudson CN, Kippin TE, Szumlinski KK.

Drug Alcohol Depend. 2017 Aug 1;177:178-186. doi: 10.1016/j.drugalcdep.2017.03.026. Epub 2017 May 24.

4.

Methamphetamine Addiction Vulnerability: The Glutamate, the Bad, and the Ugly.

Szumlinski KK, Lominac KD, Campbell RR, Cohen M, Fultz EK, Brown CN, Miller BW, Quadir SG, Martin D, Thompson AB, von Jonquieres G, Klugmann M, Phillips TJ, Kippin TE.

Biol Psychiatry. 2017 Jun 1;81(11):959-970. doi: 10.1016/j.biopsych.2016.10.005. Epub 2016 Oct 13.

Supplemental Content

Loading ...
Support Center